Comparative outcomes of adults hospitalized with seasonal influenza A or B virus infection: Application of the 7-category ordinal scale

Open Forum Infectious Diseases

Volumn 6, Issue 3, 2019, Pages

  Wang, Yeming ^a,e   Fan, Guohui ^a,e   Horby, Peter ^b   Hayden, Fredrick ^c   Li, Qian ^d   Wu, Qiaoling ^a   Zou, Xiaohui ^a   Li, Hui ^a   Zhan, Qingyuan ^a   Wang, Chen ^a,e,f   Cao, Bin ^a,e,f  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF VIRGINIA   (United States)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEKING UNION MEDICAL COLLEGE   (China)

^f TSINGHUA UNIVERSITY   (China)

Author keywords

Clinical outcomes; Hospitalization; Influenza B virus; Influenza infection; Mortality

Indexed keywords

ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; CREATINE KINASE; OSELTAMIVIR;

7 CATEGORY ORDINAL SCALE; ADULT; AGED; ARTICLE; BREATHING RATE; CLINICAL DECISION MAKING; CLINICAL OUTCOME; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE SEVERITY; DO NOT RESUSCITATE ORDER; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFLUENZA A; INFLUENZA B; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; OVERALL SURVIVAL; OXYGEN THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCORING SYSTEM; VIRUS PNEUMONIA;

EID: 85066402935     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofz053     Document Type: Article

References (18)

1. Iuliano AD, Roguski KM, Chang HH, et al; Global Seasonal Influenza-Associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285-300.
2. van de Sandt CE, Bodewes R, Rimmelzwaan GF, de Vries RD. Influenza B viruses: not to be discounted. Future Microbiol 2015; 10:1447-65.
3. Wie SH, So BH, Song JY, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS One 2013; 8:e62685.
4. Su S, Chaves SS, Perez A, et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis 2014; 59:252-5.
5. Chagvardieff A, Persico N, Marmillot C, et al. Prospective comparative study of characteristics associated with influenza A and B in adults. Med Mal Infect 2018; 48:180-7.
6. Caini S, Kroneman M, Wiegers T, et al. Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review. Influenza Other Respir Viruses 2018; 12:780-92.
7. Chinese National Influenza Center. 2017-2018 influenza season report. http:// wwwchinaivdccn/cnic/zyzx/lgzb/201801/t20180108_157998htm.
8. Garten R, Blanton L, Elal AIA, et al. Update: influenza activity in the United States during the 2017-18 season and composition of the 2018-19 influenza vaccine. MMWR Morb Mortal Wkly Rep 2018; 67:634-42.
9. Beigel JH, Tebas P, Elie-Turenne MC, et al; IRC002 Study Team. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 ran-domised study. Lancet Respir Med 2017; 5:500-11.
10. Peterson RL, Vock DM, Powers JH, et al; INSIGHT FLU-IVIG Study Group. Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization. Clin Trials 2017; 14:264-76.
11. National Health Commission of the People's Republic of China. Clinical guidance for patientswithinfluenzainfection.http://wwwnhcgovcn/xxgk/pages/viewdocumentjsp?dispatchDate=&staticUrl=%2Fyzygj%2Fpqt%2F201811%2Fdd748b43df0640e0bf 33c526ca8c9ddfshtml&wenhao=%E5%9B%BD%E5%8D%AB%E5%8A%9E %E5%8C%BB%E5%87%BD%E3%80%942018%E3%80%951020%E5%8F%B7 &utitle=%E5%85%B3%E4%BA%8E%E8%BF%9B%E4%B8%80%E6%AD% A5%E5%8A%A0%E5%BC%BA%E6%B5%81%E8%A1%8C%E6%80%A7%E6% 84%9F%E5%86%92%E5%8C%BB%E7%96%97%E5%B7%A5%E4%BD%9C%E7 %9A%84%E9%80%9A%E7%9F%A5&topictype=&topic=&publishedOrg=%E5% 8C%BB%E6%94%BF%E5%8C%BB%E7%AE%A1%E5%B1%80&indexNum= 000013610%2F2018-00308&manuscriptId=dd748b43df0640e0bf33c526ca 8c9ddf.
12. Wang Y, Guo Q, Yan Z, et al; CAP-China Network. Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection. J Infect Dis 2018; 217:1708-17.
13. Kim YH, Kim HS, Cho SH, Seo SH. Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol 2009; 22:423-30.
14. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775-85.
15. Österlund P, Strengell M, Sarin LP, et al. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 2012; 86:11183-93.
16. Gutiérrez-Pizarraya A, Pérez-Romero P, Alvarez R, et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect 2012; 65:423-30.
17. Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006; 43:439-44.
18. Ramirez J, Peyrani P, Wiemken T, et al. A randomized study evaluating the effectiveness of oseltamivir initiated at the time of hospital admission in adults hospitalized with influenza-associated lower respiratory tract infections. Clin Infect Dis 2018; 67:736-42.